121 related articles for article (PubMed ID: 32930928)
1. The effect of breast MRI on disease-free and overall survival in breast cancer patients: a retrospective population-based study.
van Nijnatten TJA; van Tiel LPT; Voogd AC; Groothuis-Oudshoorn CGM; Siesling S; Lobbes MBI
Breast Cancer Res Treat; 2020 Dec; 184(3):951-963. PubMed ID: 32930928
[TBL] [Abstract][Full Text] [Related]
2. Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials.
Dayan D; Lukac S; Rack B; Ebner F; Fink V; Leinert E; Veselinovic K; Schütze S; El Taie Z; Janni W; Friedl TWP
Breast Cancer Res; 2023 Dec; 25(1):153. PubMed ID: 38098086
[TBL] [Abstract][Full Text] [Related]
3. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
4. Impact of invasive lobular carcinoma on long-term outcomes in Mexican breast cancer patients.
Flores-Díaz D; Arce C; Flores-Luna L; Reynoso-Noveron N; Lara-Medina F; Matus JA; Bargallo-Rocha E; Pérez V; Villarreal-Garza C; Cabrera-Galeana P; Mohar A
Breast Cancer Res Treat; 2019 Jul; 176(1):243-249. PubMed ID: 30997623
[TBL] [Abstract][Full Text] [Related]
5. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
6. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival outcomes in invasive lobular carcinoma patients with and without preoperative MR imaging: a matched cohort study.
Ha SM; Chae EY; Cha JH; Kim HH; Shin HJ; Choi WJ
Eur Radiol; 2019 May; 29(5):2526-2534. PubMed ID: 30617471
[TBL] [Abstract][Full Text] [Related]
8. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
9. Breast MRI in Invasive Lobular Carcinoma: A Useful Investigation in Surgical Planning?
Parvaiz MA; Yang P; Razia E; Mascarenhas M; Deacon C; Matey P; Isgar B; Sircar T
Breast J; 2016; 22(2):143-50. PubMed ID: 26841281
[TBL] [Abstract][Full Text] [Related]
10. Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences.
Kwast AB; Groothuis-Oudshoorn KC; Grandjean I; Ho VK; Voogd AC; Menke-Pluymers MB; van der Sangen MJ; Tjan-Heijnen VC; Kiemeney LA; Siesling S
Breast Cancer Res Treat; 2012 Aug; 135(1):271-80. PubMed ID: 22810087
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
12. Invasive Pleomorphic Lobular Histology Is an Adverse Prognostic Factor on Survival in Patients with Breast Cancer.
Sahin S; Karatas F; Erdem GU; Hacioglu B; Altundag K
Am Surg; 2017 Apr; 83(4):359-364. PubMed ID: 28424130
[TBL] [Abstract][Full Text] [Related]
13. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
[TBL] [Abstract][Full Text] [Related]
14. Long-term Survival Outcomes of Primary Breast Cancer in Women With or Without Preoperative Magnetic Resonance Imaging: A Matched Cohort Study.
Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY; Jung KH; Ahn JH; Kim SB; Son BH; Ahn SH
Clin Oncol (R Coll Radiol); 2017 Oct; 29(10):653-661. PubMed ID: 28728883
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in women with invasive ductal or invasive lobular early stage breast cancer treated with anastrozole or exemestane in CCTG (NCIC CTG) MA.27.
Strasser-Weippl K; Sudan G; Ramjeesingh R; Shepherd LE; O'Shaughnessy J; Parulekar WR; Liedke PER; Chen BE; Goss PE
Eur J Cancer; 2018 Feb; 90():19-25. PubMed ID: 29274617
[TBL] [Abstract][Full Text] [Related]
16. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
17. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation.
Carbognin L; Sperduti I; Fabi A; Dieci MV; Kadrija D; Griguolo G; Pilotto S; Guarneri V; Zampiva I; Brunelli M; Orvieto E; Nortilli R; Fiorio E; Parolin V; Manfrin E; Caliò A; Nisticò C; Pellini F; Scarpa A; Pollini GP; Conte P; Tortora G; Bria E
Breast; 2017 Oct; 35():21-26. PubMed ID: 28628772
[TBL] [Abstract][Full Text] [Related]
19. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
Resende U; Cabello C; Ramalho SOB; Zeferino LC
BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
[TBL] [Abstract][Full Text] [Related]
20. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]